Cun-Yu Wang Selected Research

Cun-Yu Wang Research Topics

Disease

38	Neoplasms (Cancer) 01/2021 - 07/2002
18	Squamous Cell Carcinoma of Head and Neck 01/2021 - 07/2002
11	Neoplasm Metastasis (Metastasis) 01/2021 - 07/2002
6	Osteoporosis 01/2022 - 07/2008
6	Inflammation (Inflammations) 01/2019 - 10/2003
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 09/2005
5	Carcinogenesis 01/2020 - 04/2002
3	Bone Resorption 01/2022 - 01/2007
3	Periodontitis 01/2022 - 10/2006
3	Breast Neoplasms (Breast Cancer) 04/2013 - 01/2007
2	Mouth Neoplasms (Oral Cancer) 12/2023 - 05/2018
2	Lymphatic Metastasis 01/2021 - 01/2017
2	Bites and Stings (Sting) 01/2021 - 01/2015
2	Colorectal Neoplasms (Colorectal Cancer) 11/2019 - 01/2017
2	Metabolic Bone Diseases (Osteopenia) 01/2016 - 07/2012
2	Periodontal Diseases (Periodontal Disease) 01/2016 - 07/2004
2	Inborn Genetic Diseases (Disease, Hereditary) 12/2014 - 02/2004
2	Prostatic Neoplasms (Prostate Cancer) 10/2013 - 09/2005
2	Chronic Periodontitis 03/2013 - 12/2009
2	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 04/2010 - 11/2006
2	Virus Diseases (Viral Diseases) 02/2010 - 04/2009
2	RNA Virus Infections 02/2010 - 04/2009
2	Adenoid Cystic Carcinoma (Cylindroma) 02/2009 - 01/2009
1	Postmenopausal Osteoporosis 01/2022
1	Hepatomegaly 01/2020
1	Hypertrophy 01/2020
1	Uveal melanoma 01/2020
1	Chronic Kidney Failure (Chronic Renal Failure) 10/2019
1	Myocardial Infarction 10/2019
1	Atherosclerosis 01/2019
1	Cleft Lip (Harelip) 01/2017
1	Fetal Alcohol Spectrum Disorders 01/2016
1	Alveolar Bone Loss 12/2015
1	Reinfection 11/2015
1	Infections 11/2015

Drug/Important Bio-Agent (IBA)

14	NF-kappa B (NF-kB)IBA 12/2015 - 09/2003
8	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2007
6	Transcription Factors (Transcription Factor)IBA 10/2013 - 10/2003
6	beta CateninIBA 07/2010 - 04/2002
5	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 04/2003
5	Bortezomib (Velcade)FDA Link 01/2016 - 11/2004
4	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 10/2006
4	CateninsIBA 11/2019 - 12/2013
4	Proteasome InhibitorsIBA 01/2016 - 11/2004
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2014 - 09/2003
3	CytokinesIBA 01/2022 - 01/2010
3	LipopolysaccharidesIBA 01/2019 - 12/2009
3	Phosphotransferases (Kinase)IBA 05/2018 - 01/2010
2	Estrogens (Estrogen)FDA Link 01/2022 - 01/2017
2	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2020 - 01/2017
2	LigandsIBA 10/2019 - 07/2005
2	diphosphoric acid (pyrophosphoric acid)IBA 10/2019 - 07/2012
2	TOR Serine-Threonine KinasesIBA 01/2016 - 12/2007
2	trichostatin A (A 300)IBA 01/2016 - 07/2010
2	Histone Deacetylase InhibitorsIBA 01/2016 - 07/2010
2	Interferon Type IIBA 01/2015 - 02/2010
2	Virulence Factors (Pathogenicity Factors)IBA 03/2013 - 12/2009
2	Small Interfering RNA (siRNA)IBA 01/2011 - 01/2010
2	CaspasesIBA 07/2010 - 11/2004
2	Nucleic AcidsIBA 02/2010 - 04/2009
2	Antiviral Agents (Antivirals)IBA 02/2010 - 04/2009
2	Proteasome Endopeptidase Complex (Proteasome)IBA 07/2006 - 11/2004
2	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 12/2002 - 07/2002
2	SuspensionsIBA 12/2002 - 07/2002
1	Biomarkers (Surrogate Marker)IBA 12/2023
1	Estrogen ReceptorsIBA 01/2022
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 01/2022
1	Lysine (L-Lysine)FDA Link 01/2021
1	HeterochromatinIBA 01/2021
1	Histones (Histone)IBA 01/2021
1	Circular RNAIBA 01/2021
1	AntibodiesIBA 01/2021
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 09/2020
1	Programmed Cell Death 1 ReceptorIBA 01/2020
1	KPT-9274IBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	p21-Activated KinasesIBA 01/2020
1	ApolipoproteinsIBA 01/2019
1	LipidsIBA 01/2019
1	CarcinogensIBA 05/2018
1	Cadherins (E-Cadherin)IBA 05/2018
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2017
1	Group IV Phospholipases A2IBA 01/2017
1	NanodiamondsIBA 01/2017
1	HydrogelsIBA 01/2017
1	Histone Deacetylase 6IBA 01/2016
1	OsteocalcinIBA 01/2016
1	MineralsIBA 01/2016
1	Amoxicillin (Wymox)FDA LinkGeneric 11/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2015
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 10/2015

Therapy/Procedure

14	Therapeutics 01/2022 - 06/2006
4	Drug Therapy (Chemotherapy) 01/2021 - 01/2016
4	Immunotherapy 01/2021 - 09/2019
2	Ovariectomy (Oophorectomy) 09/2014 - 07/2008
1	Rejuvenation 01/2021
1	Radiotherapy 09/2019
1	Ligation 01/2019
1	Injections 01/2017
1	Root Canal Therapy 11/2015